Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Cytochrome c polymerization by successive domain swapping at the C-terminal helixShun Hirota, Yoko Hattori, Satoshi Nagao, et al.
Plos One|February 26, 2026
A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocolTomoya Kurokawa, Tomohisa Iinuma, Haruna Ebisu, et al.
Nature|August 21, 2009
The ethylene response factors SNORKEL1 and SNORKEL2 allow rice to adapt to deep waterYoko Hattori, Keisuke Nagai, Shizuka Furukawa, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|May 20, 2021
Improvements of Retinal Sensitivity after Intravitreal Injection of Aflibercept in Eyes with Neovascular Age-Related Macular Degeneration with or without Polypoidal Choroidal VasculopathyTomohiro Nizawa, Masayasu Kitahashi, Takayuki Baba, et al.
Metabolites|February 21, 2020
Metabolite and Phytohormone Profiling Illustrates Metabolic Reprogramming as an Escape Strategy of Deepwater Rice during Partially Submerged StressAtsushi Fukushima, Takeshi Kuroha, Keisuke Nagai, et al.
Drug Discoveries & Therapeutics|December 10, 2025
A phase II investigator-initiated, continuation trial of 5-aminolevulinic acid hydrochloride/sodium ferrous citrate (5-ALA-HCl/SFC) for patients with adult-onset Still's disease (AOSD) refractory to glucocorticoidsRemi Sumiyoshi, Tomohiro Koga, Osamu Kamisawa, et al.
Cureus|September 19, 2025
A Phase-II Investigator-Initiated Randomized, Double-Blind, Parallel-Group Clinical Trial of 5-Aminolevulinic Acid Hydrochloride/Sodium Ferrous Citrate (5-ALA-HCl/SFC) for Patients With Adult-Onset Still's Disease (AOSD) Refractory to CorticosteroidsRemi Sumiyoshi, Tomohiro Koga, Osamu Kamisawa, et al.
BMJ Open|March 3, 2022
Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm studyNoriyuki Okonogi, Hirokazu Usui, Kazutoshi Murata, et al.
BMJ Open|May 13, 2026
Evaluating postoperative pneumatic lymphatic drainage following lymphaticovenous anastomosis for secondary lower extremity lymphoedema in Japan (LVA-PLD trial): protocol for a multicentre randomised controlled trialShinsuke Akita, Rei Nishioka, Haruna Tokunaga, et al.
International Journal of Molecular Sciences|July 14, 2023
A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy ResultsNoriyuki Okonogi, Kazutoshi Murata, Shigeru Yamada, et al.
Pageof 2